Thursday, November 20, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Lockheed Martin Shares: Poised for a Breakout?

Felix Baarz by Felix Baarz
November 20, 2025
in Analysis, Defense & Aerospace, S&P 500
0
Lockheed Stock
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The American defense behemoth finds itself in a curious position. Despite analysts upgrading their earnings forecasts and the promise of multi-billion dollar contracts on the horizon, its stock price remains stagnant. Trading around $470, the shares are languishing below their 50-day moving average, even as strong fundamental catalysts appear ready to propel them forward. Is the market’s valuation about to catch up with the company’s robust business trajectory?

A Major Contract Catalyst: The Saudi F-35 Deal

Beyond optimistic earnings revisions, concrete contract wins are providing significant momentum. While Lockheed Martin recently secured a $12.4 million contract increase for its THAAD missile defense system, this is merely a prelude to a much larger opportunity. The impending F-35 export deal to Saudi Arabia holds far greater financial significance.

Market experts at Jefferies estimate this single agreement could generate approximately $4 billion in sales. This substantial long-term revenue driver is projected to contribute roughly $1.50 per share, a figure the market does not yet seem to have fully priced into the current stock value.

Diverging Analyst Views: From Hold to High Conviction

Wall Street’s outlook on the stock’s near-term potential is mixed. The prevailing consensus recommendation remains a “Hold,” with average price targets clustering between $513 and $518. However, Morgan Stanley presents a notably bullish counterpoint. The firm has assigned an “Overweight” rating to Lockheed Martin, accompanied by a standout $630 price target. This projection implies an upside potential exceeding 30 percent from current levels, signaling strong conviction in the company’s growth story.

Should investors sell immediately? Or is it worth buying Lockheed?

Seaport’s Bullish Earnings Revision

Adding to the positive sentiment, Seaport Research Partners recently issued a notably optimistic assessment. The firm has meaningfully raised its full-year 2025 profit expectation to $28.11 per share, a significant jump from its previous forecast of $27.82. This adjustment places Seaport well above the current market consensus, which sits at approximately $27.15 per share, and indicates growing confidence in the corporation’s operational strength.

Looking further ahead, Seaport anticipates a consistent growth trajectory through 2026, with quarterly projections as follows:
* Q1 2026: $6.85
* Q2 2026: $7.21
* Q3 2026: $7.33
* Q4 2026: $7.97

The current technical weakness, with the share price trading below its 50-day average, stands in stark contrast to these underlying fundamental strengths. For investors betting on a market reassessment, this disconnect may present a compelling opportunity.

Ad

Lockheed Stock: Buy or Sell?! New Lockheed Analysis from November 20 delivers the answer:

The latest Lockheed figures speak for themselves: Urgent action needed for Lockheed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 20.

Lockheed: Buy or sell? Read more here...

Tags: Lockheed
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Bionxt Solutions Stock
Analysis

BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets

November 20, 2025
Nestle Stock
Analysis

Nestlé Shares Secure Crucial Legal and Strategic Wins

November 20, 2025
aTyr Pharma Stock
Analysis

aTyr Pharma Shares Plummet Following Clinical Trial Failure

November 20, 2025
Next Post
Coinbase Stock

Coinbase's Strategic Expansion Meets Insider Selling Pressure

BioNTech Stock

Pfizer's BioNTech Divestment Sends Shockwaves Through Markets

aTyr Pharma Stock

aTyr Pharma Shares Plummet Following Clinical Trial Failure

Recommended

Eli Lilly and Stock

Eli Lilly Shares Surge as Analysts Boost Ratings

1 month ago
Consumer Portfolio Services Stock

Subprime Auto Lender CPSS Sees Sharp Single-Day Rally Amid Longer-Term Decline

1 month ago
Finance_Financialization

Analyst Ratings and Price Targets for Advance Auto Parts A Breakdown

2 years ago
Blackstone Stock

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Diginex Shares Surge on Strategic Partnership Announcement

Cardano’s Institutional Surge: Whales Drive Market Momentum

aTyr Pharma Shares Plummet Following Clinical Trial Failure

Pfizer’s BioNTech Divestment Sends Shockwaves Through Markets

Coinbase’s Strategic Expansion Meets Insider Selling Pressure

Lockheed Martin Shares: Poised for a Breakout?

Trending

Redcare Pharmacy Stock
E-Commerce

Redcare Pharmacy Stock Finds Hope with Key Amazon Hire

by Andreas Sommer
November 20, 2025
0

After a punishing year that saw its value cut in half, Redcare Pharmacy shares are attracting renewed...

Bionxt Solutions Stock

BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets

November 20, 2025
Nestle Stock

Nestlé Shares Secure Crucial Legal and Strategic Wins

November 20, 2025
Diginex Stock

Diginex Shares Surge on Strategic Partnership Announcement

November 20, 2025
Cardano Stock

Cardano’s Institutional Surge: Whales Drive Market Momentum

November 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Redcare Pharmacy Stock Finds Hope with Key Amazon Hire
  • BioNxt Solutions Secures Key Patent Protection Across Eurasian Markets
  • Nestlé Shares Secure Crucial Legal and Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com